Biocryst Pharmaceuticals (BCRX) Change in Cash: 2010-2015
Historic Change in Cash for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Dec 2015 value amounting to -$17.7 million.
- Biocryst Pharmaceuticals' Change in Cash rose 73.39% to -$17.7 million in Q4 2015 from the same period last year, while for Dec 2015 it was -$25.6 million, marking a year-over-year decrease of 176.82%. This contributed to the annual value of -$6.1 million for FY2024, which is 96.84% up from last year.
- According to the latest figures from Q4 2015, Biocryst Pharmaceuticals' Change in Cash is -$17.7 million, which was up 41.21% from -$30.2 million recorded in Q3 2015.
- In the past 5 years, Biocryst Pharmaceuticals' Change in Cash registered a high of $107.9 million during Q2 2014, and its lowest value of -$66.6 million during Q4 2014.
- Over the past 3 years, Biocryst Pharmaceuticals' median Change in Cash value was -$5.5 million (recorded in 2013), while the average stood at $667,333.
- In the last 5 years, Biocryst Pharmaceuticals' Change in Cash surged by 2,075.23% in 2014 and then tumbled by 8,229.83% in 2015.
- Quarterly analysis of 5 years shows Biocryst Pharmaceuticals' Change in Cash stood at -$6.0 million in 2011, then surged by 48.84% to -$3.1 million in 2012, then plummeted by 59.26% to -$4.9 million in 2013, then crashed by 1,263.43% to -$66.6 million in 2014, then skyrocketed by 73.39% to -$17.7 million in 2015.
- Its Change in Cash stands at -$17.7 million for Q4 2015, versus -$30.2 million for Q3 2015 and $28.4 million for Q2 2015.